Abstract: A computer-implemented method comprises: reading in sensor data relating to an image file; assigning the sensor data to a first position of a patient's anatomical structure; extracting at least one second position of the patient's anatomical structure from a medical diagnostic report; comparing the first position and the at least one second position; and outputting a warning signal if the comparison does not yield a match.

Abstract: A computer-implemented method for planning and/or controlling a production by a production system comprising a plurality of production sections and production lines. A production planning and/or control system for production optimization is also disclosed.

Abstract: A computer-implemented method for planning and/or controlling a production by a production system comprising a plurality of production sections and production lines. A production planning and/or control system are also disclosed.

Abstract: The invention relates to a means of prevention and therapy of hormone-sensitive tumour tissue, especially for the prevention and/or inhibition of mammary carcinoma or prostate carcinoma. The composition according to the invention is characterised by comprising steroid hormones and aromatase inhibitors. This is preferably a triple combination of the steroid hormones oestriol (E3), progesterone and testosterone and an aromatase inhibitor. Another object of the invention is the use of the composition according to the invention for the manufacture of a drug for the prevention and therapy of hormone-sensitive tumours, preferably the mammary carcinoma or the prostate carcinoma.

Abstract: The invention relates to a method for establishing the sensitivity of tumors towards capecitabine, if applicable in combination with Docetaxel or Paclitaxel or the humanized antibody Herceptin, or COX-2 inhibitors or angiogenesis inhibitors and test kit. Fields of application of the invention are the pharmaceutical industry and bio-sciences: biology, biochemistry, biotechnology, medicine and medicinal technology.

Abstract: The invention relates to a method for establishing the sensitivity of tumors towards capecitabine, if applicable in combination with Docetaxel or Paclitaxel or the humanized antibody Herceptin, or COX-2 inhibitors or angiogenesis inhibitors and test kit. Fields of application of the invention are the pharmaceutical industry and bio-sciences: biology, biochemistry, biotechnology, medicine and medicinal technology.

Abstract: A pharmacologically active composition which is suitable for use in palliative cancer therapy and as an agent having a muscle-relaxing and/or analgetic effect in neurological diseases. Said composition contains at least 80 wt. %, preferbly 90 wt. %, tetrahydrocannabinol (THC) an cannabidiol (CBD), in relation to the overall weight of cannabinoids present therein. The weight ratio of THC to CBD=75:25-20:80, preferably 3:1-1:2, an especially 2:1. Said composition can be used for the production of pharmacologically effective agents which can be used in palliative cancer therapy and in the treatment of neurological disease.

Abstract: A pharmacologically active composition which is suitable for use in palliative cancer therapy and as an agent having a muscle-relaxing and/or analgetic effect in neurological diseases. Said composition contains at least 80 wt. %, preferably 90 wt. %, tetrahydrocannabinol (THC) and cannabidiol (CBD), in relation to the overall weight of cannabinoids present therein. The weight ratio of THC to CBD=75:25-20:80, preferably 3:1-1:2, and especially 2:1. Said composition can be used for the production of pharmacologically effective agents which can be used in palliative cancer therapy and in the treatment of neurological diseases.

Abstract: The invention is concerned with a means for the therapy of malignant diseases, in particular for the prevention or inhibition of metastases of solid tumours expressing HER2. The means in keeping with this invention is characterized by the fact that it favours the expression of the Keratin genes 8 and 18 (K8, K18) in tumour cells. The K18 gene is preferred for the gene therapeutic treatment and it is preferential for the HER2-mediated in vivo transfection with a liposomal capsule equipped with antibodies against the HER2 receptor. The subject of the invention is thus the use of the K8 and K18 genes for the therapy of solid tumours, in particular for breast cancer. Areas of application for the invention are in medicine and the pharmaceutical industry.

Abstract: To monitor an electrode lead composed of two lines in a bipolar HVDCT system, a balanced-to-ground pulse formed from an unbalanced-to-ground pulse in push/pull mode is fed into the lines and an actual echo curve is recorded from the echo signals and compared to a dynamic target echo curve, a fault signal being generated when a tolerance band placed around the echo difference curve is exceeded. In this way, a monitoring method is achieved which is nearly independent of the sharply fluctuating ground conductance, which has a higher range with simultaneously lower dispersion of the echo, which radiates less electromagnetic energy and which requires no additional decoupling elements.

Abstract: For a selective sound propagation pattern that has an especially high directivity, including in the bass frequency region, there is inventively provided a loudspeaker box (1) with a housing (2) and at least one loudspeaker (4) with chassis (6) which is surrounded by a housing wall (8) in such a way that in the low frequency region the rear side and front side sound of the loudspeaker (4) overlay themselves with a sound increase in a preferred direction.

Abstract: A change-speed gearbox of a motor vehicle includes a shifting element moveable within a plurality of shift gates for engaging and disengaging a selected gear. A gearshift member cooperates with the gear shifting element. The gearshift member is movable to perform a rotary shift movement and a linear shift movement. A shift device for the gearbox includes a motor having a shaft extending therefrom rotatable about an axis. The gearshift member is axially slidably supported by the motor shaft and rotatably engaged therewith. A solenoid is engaged with the gearshift member for slidably axially moving the gearshift member into a plurality of positions corresponding with the shift gates.

Abstract: An electric gearshift mechanism for a change-speed gearbox of a motor vehicle with selector gates has an electric motor and a gear shifting member. The gear shifting member can be moved in two substantially mutually transverse shifting movements. The gear shifting member includes a threaded spindle having an axis of rotation drivably connected to the motor carrying a nut having a finger for preselecting selector gates. A linear guide conducts the nut along the axis and a clutch rotatably connects the nut and the spindle.